Development of novel CD19 CAR-T cell therapy with enhanced antitumor effect for B cell malignancies

Hiroshi Miwa

Presentation information

Oral Session

Oral Session 2-14B Gene-modified T Cell Therapy

Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.14 (Tokyo International Forum, 6F G610)

Chair: Yoshiki Akatsuka (Department of Immunology, Graduate School of Medicine, Nagoya University)

[OS2-14B-1] Development of novel CD19 CAR-T cell therapy with enhanced antitumor effect for B cell malignancies

Hiroshi Miwa¹, Hiroshi Fujiwara¹, Yasushi Akahori¹, Linan Wang¹, Satoshi Okumura¹, Yoshimasa Tanaka², Takuma Kato¹, Yoshihiro Miyahara¹, Hiroshi Shiku¹ (1.Personalized Cancer Immunotherapy, Mie Univ., Japan, 2.Center for Bioinformatics and Molecular Medicine, Nagasaki Univ., Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.